deferoxamine has been researched along with Canine Diseases in 4 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The iron-chelating agent deferoxamine (DF) was administered as a single dose and also daily over a prolonged period to evaluate availability of storage iron in dogs with induced anemia of inflammatory disease." | 3.66 | Anemia of inflammatory disease in the dog: availability of storage iron in inflammatory disease. ( Farver, TB; Feldman, BF; Kaneko, JJ, 1981) |
| " Chelation therapy with desferrioxamine mesylate did not cause adverse effects in any of the dogs and all survived to discharge." | 1.35 | Acute toxicity in five dogs after ingestion of a commercial snail and slug bait containing iron EDTA. ( Davis, RM; Haldane, SL, 2009) |
| "In dogs, gastric dilatation-volvulus (GDV) is characterized by cardiogenic shock, with resulting hypoperfusion." | 1.28 | Treatment of reperfusion injury in dogs with experimentally induced gastric dilatation-volvulus. ( Arkin, TE; Badylak, SF; Hiles, MC; Lantz, GC, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, RN | 1 |
| Levenhagen, MA | 1 |
| Levenhagen, MM | 1 |
| Rieck, SE | 1 |
| Labruna, MB | 1 |
| Beletti, ME | 1 |
| Haldane, SL | 1 |
| Davis, RM | 1 |
| Feldman, BF | 1 |
| Kaneko, JJ | 1 |
| Farver, TB | 1 |
| Lantz, GC | 1 |
| Badylak, SF | 1 |
| Hiles, MC | 1 |
| Arkin, TE | 1 |
4 other studies available for deferoxamine and Canine Diseases
| Article | Year |
|---|---|
The spreading process of Ehrlichia canis in macrophages is dependent on actin cytoskeleton, calcium and iron influx and lysosomal evasion.
Topics: Actin Cytoskeleton; Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytochalasins; Defe | 2014 |
Acute toxicity in five dogs after ingestion of a commercial snail and slug bait containing iron EDTA.
Topics: Animals; Deferoxamine; Dog Diseases; Dogs; Female; Gastrointestinal Diseases; Iron; Male; Siderophor | 2009 |
Anemia of inflammatory disease in the dog: availability of storage iron in inflammatory disease.
Topics: Anemia; Animals; Biological Availability; Deferoxamine; Dog Diseases; Dogs; Female; Ferritins; Hemos | 1981 |
Treatment of reperfusion injury in dogs with experimentally induced gastric dilatation-volvulus.
Topics: Animals; Deferoxamine; Dimethyl Sulfoxide; Disease Models, Animal; Dog Diseases; Dogs; Gastric Dilat | 1992 |